Chikungunya

27 registered clinical trials studyying Chikungunya — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Phase I Study of PepGNP-ChikV in Healthy Volunteers NCT07394426	Gylden Pharma Ltd	EARLY_Phase 1
Not Yet Recruiting	Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikung NCT06973772	Butantan Institute	Phase 3
Completed	Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities NCT07517731	University of Freiburg	N/A
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Not Yet Recruiting	Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections NCT07112846	Hospital Israelita Albert Einstein	—
Completed	Trial of an Inactivated Chikungunya Virus Vaccine NCT06669208	Najit Technologies, Inc.	Phase 1
Terminated	Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale NCT06595745	Michigan State University	N/A
Completed	Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and A NCT06257810	BioMérieux	N/A
Completed	Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years NCT04838574	Centre Hospitalier Universitaire de la Réunion	—
Completed	Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu NCT05153018	Institut Pasteur	N/A
Completed	A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolesce NCT04650399	Butantan Institute	Phase 3
Terminated	Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asi NCT04566484	International Vaccine Institute	Phase 2 / Phase 3
Suspended	Baromètre Santé Adulte 2021-2022 NCT05218304	Agence Sanitaire et Sociale de Nouvelle Calédonie	N/A
Recruiting	Virological and Immunological Determinants of Arbovirus Infection in New Caledonia NCT04619823	Institut Pasteur	N/A
Completed	Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia NCT04434846	National Institute of Allergy and Infectious Diseases (NIAID)	—
Unknown	Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Fo NCT04672577	Patricia Schlagenhauf	—
Completed	Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases NCT04343521	Emory University	N/A
Completed	Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. NCT04440774	University of Oxford	Phase 1
Recruiting	Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia NCT04615364	Institut Pasteur	—
Completed	Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) NCT03992872	Bavarian Nordic	Phase 2
Completed	Defining Skin Immunity of a Bite of Key Insect Vectors in Humans NCT03641339	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Completed	Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Vo NCT03382964	Valneva Austria GmbH	Phase 1
Completed	Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area NCT03101111	Themis Bioscience GmbH	Phase 2
Completed	Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine NCT04603131	Bharat Biotech International Limited	Phase 1
Completed	Chikungunya Arthritis in the Americas NCT02463968	George Washington University	—
Completed	The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico NCT02831699	Mexican Emerging Infectious Diseases Clinical Research Network	—
Unknown	Cohort of Patients Infected by an Arbovirus NCT01099852	University Hospital Center of Martinique	—